Xeris Pharmaceuticals | XERS - 流动资产

金融业

USD

USD 392.01M

现金及等价物

USD 111.75M

USD 10.57M

USD 251.68M

USD 118.59M

USD 258.55M

USD 9.12M

USD 12.33M

377

EPS每股收益

USD 0.01

股本和储备

USD 13.01M

USD 72.55M

债务利息支出

USD 6.88M

USD 1.2M

USD 221.22M

USD 1.26B

USD 2.23M

USD 75.21M

USD 7.92M

普通股股本

USD 172.56M

76.05

USD 2.23M

USD 83.13M

销售和管理费用

USD 53.14M

USD 74.23M

贸易债权人

USD 11.47M

应收帐款人

USD 56.3M

	流动资产	更改		日
Celltrion	KRW 481.57B		10.97B	2026-03
Cspc Pharmaceutical	CNY 22.25B		359.48M	2025-12
Deva Holding AS	TRY 9.13B		1.61B	2023-09
Dianthus Therapeutics	USD 1.12B		710.47M	2026-03
Divis Laboratories Ltd	INR 110.96B		12.53B	2026-03
Eli Lilly	USD 54.84B		794M	2026-03
Kangmei Pharma	CNY 6.8B		225.83M	2026-03
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Laboratorios Farma	EUR 509.33M		128.63M	2023-12
Malin Corporation	EUR 62.6M		26.7M	2024-12
Medical Developments International	AUD 33.75M		1.79M	2025-12
Nektar Therapeutics	USD 266.27M		15.09M	2025-12
Neuren Pharmaceuticals	AUD 332.23M		11.98M	2025-12
Organigram Holdings	CAD 250.09M		6.46M	2026-03
Ovoca Bio	EUR 1.56M		3.39M	2025-06
Pacira	USD 514.96M		33.01M	2026-03
Perrigo	USD 2.71B		85M	2026-03
Pharma Mar	EUR 273.45M		9.96M	2026-03
Qiagen NV	USD 2B		535.87M	2025-12
Sartorius	EUR 1.92B		157.2M	2026-03
Sino Biopharmaceutical	CNY 33.82B		9.13B	2025-06
Supernus Pharmaceuticals	USD 731.58M		87.4M	2026-03
Tilray	USD 729.32M		28.18M	2025-09
Zealand Pharma A/S	15.67B		950.94M	2025-12
Zz Pientze Pharmaceu	CNY 11.43B		728.95M	2026-03